Live feed
Filing
SC 13D/A
SC 13D/A0001213900-17-010642·REGENERX BIOPHARMACEUTICALS INC
Schedule 13D ownership disclosure
REGENERX BIOPHARMACEUTICALS CO
Security class unavailable · CUSIP: 75886X108
Event date: 2017-10-13
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 13,921,726
- Percent of class
- 12.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-17-010642
- Form type
- SC 13D/A
- Filer
- REGENERX BIOPHARMACEUTICALS INC
- CIK
- CIK 707511
- Filed
- Oct 17, 2017
- Reporting period
- Oct 13, 2017
- Description
- Schedule 13D beneficial ownership